Philip Lazarus

14PUBLICATIONS
111CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Behavioural epidemiologyPredictive and prognostic markersToxicology (incl. clinical toxicology)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 19, 2026
Large-scale association study identifies lung cancer susceptibility copy number variants and their potential functional role in genetic instability.

|Jan 05, 2024
Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies.

Yafang Li, Xiangjun Xiao, Jianrong Li

|Dec 20, 2023
CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility.

Mulong Du, Junyi Xin, Rui Zheng

|Sep 07, 2023
Hydrocodone, Oxycodone, and Morphine Metabolism and Drug-Drug Interactions.

Shelby Coates, Philip Lazarus

|Jan 10, 2023
Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD).

Shamema Nasrin, Shelby Coates, Keti Bardhi

|Oct 17, 2022
Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers.

Yadira X Perez-Paramo, Christy J W Watson, Gang Chen

Pageof 3

Frequent Collaborators

4 joint publications

Gadi Rennert

4 joint publications

John K Field

4 joint publications

Christopher I Amos

4 joint publications

Christy J W Watson